BRIEF-Aurinia Pharma Q1 loss per share $0.13

Wed May 11, 2016 5:35pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 11 (Reuters) - Aurinia Pharmaceuticals Inc

* Q1 loss per share $0.13

* To complete aura ln clinical trial, undertake further development of voclosporin, co will need to raise additional funds within next 12 months

* Q1 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S

* Aurinia reports first quarter 2016 financial results and operational highlights Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)